Filing Details
- Accession Number:
- 0001437749-25-002685
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-04 11:51:51
- Reporting Period:
- 2025-01-31
- Filing Date:
- 2025-02-04
- Accepted Time:
- 2025-02-04 11:51:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1668243 | Urogen Pharma Ltd. | URGN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1821479 | Drew Jason Smith | 400 Alexander Park Drive Princeton NJ 08540 | General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2025-01-31 | 2,500 | $0.00 | 27,726 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2025-01-31 | 1,258 | $11.14 | 26,468 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2025-01-31 | 6,667 | $0.00 | 33,135 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2025-01-31 | 3,354 | $11.14 | 29,781 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2025-01-31 | 5,500 | $0.00 | 35,281 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2025-01-31 | 2,767 | $11.14 | 32,514 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Restricted Stock Units | Disposition | 2025-01-31 | 2,500 | $0.00 | 2,500 | $0.00 |
| Ordinary Shares | Restricted Stock Units | Disposition | 2025-01-31 | 6,667 | $0.00 | 6,667 | $0.00 |
| Ordinary Shares | Restricted Stock Units | Disposition | 2025-01-31 | 5,500 | $0.00 | 5,500 | $0.00 |
| Ordinary Shares | Restricted Stock Units | Acquisiton | 2025-01-31 | 10,000 | $0.00 | 10,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct | ||
| 6,667 | No | 4 | M | Direct | ||
| 11,000 | No | 4 | M | Direct | ||
| 10,000 | No | 4 | A | Direct |
Footnotes
- Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
- Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.
- The reporting person was granted RSUs on January 31, 2022 representing 7,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2023.
- The reporting person was granted RSUs on January 31, 2023 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024.
- The reporting person was granted RSUs on January 31, 2024 representing 16,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2025.
- 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2026, January 31, 2027 and January 31, 2028.
Billionaire Hedge Funds
